VEGFA and neoplasm: Thus, the combined administration of LCL-PLP and LCL-DOX exerted complementary suppressive action on the production of both angiogenic factors in tumor tissue (65% reduction for bFGF levels (p < 0.0001) and 89% reduction for VEGF levels (p < 0.0001)) compared with their control tumor expression (Table 1).